The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 6, 1998, Pages 807-810

  Schmitz, Franz Josef ^a,b   Fluit, Ad C ^b   Lückefahr, Marc ^a   Engler, Beate ^a   Hofmann, Basia ^a   Verhoef, Jan ^b   Heinz, Hans Peter ^a   Hadding, Ulrich ^a   Jones, Mark E ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; CIPROFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; SPARFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; GENES, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; QUINOLINES; RESERPINE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0032445682     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.6.807     Document Type: Article

References (10)

1. Ferrero, L., Cameron, B. & Crouzet, J. (1995). Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 33, 1554-8.
2. Kaatz, G. W. & Seo, S. M. (1995). Inducible norA-mediated multidrug resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 39, 2650-5.
3. Neyfakh, A. A., Borsch, C. M. & Kaatz G. W. (1993). Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrobial Agents and Chemotherapy 37, 128-9.
4. Kaatz, G. W., Seo, S. M. & Ruble, C. A. (1993). Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 37, 1086-94.
5. Markham, P. N. & Neyfakh, A. A. (1996). Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 40, 2673-4.
6. Schmitz, F. J., Steiert, M., Tichy, H.-V., Hofmann, B., Verhoef, J., Heinz, H.-P. et al. (1998). Typing of methicillin-resistant Staphylococcus aureus isolates from Düsseldorf by six genotypic methods. Journal of Medical Microbiology 47, 341-51.
7. Schmitz, F. J., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Klootwijk, M. et al. (1998). Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 41, 481-4.
8. 50: an exactly defined measure of antibiotic sensitivity. Journal of Antimicrobial Chemotherapy 29, 137-9.
9. Schmitz, F.-J., Hertel, B., Hofmann, B., Scheuring, S., Verhoef, J., Fluit, A. C. et al. (1998). Correlation of norfloxacin MIC-values with mutations within the coding and promotor region of the norA gene in 42 unrelated clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 42, 561-3.
10. Ahmed, M., Borsch, C. M., Neyfakh, A. A. & Schuldiner, S. (1993). Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. Journal of Biological Chemistry 268, 11086-9.